共 57 条
[1]
Guo Y(2013)Heart failure in East Asia Curr Cardiol Rev 9 112-122
[2]
Lip GY(1987)Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) N Engl J Med 316 1429-1435
[3]
Banerjee A(1991)Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 293-302
[4]
Yusuf S(2001)Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure N Engl J Med 345 1667-1675
[5]
Pitt B(2022)2022 AHA/ACC/HFSA Guideline for the management of heart failure: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines Circulation 145 e876-ee94
[6]
Davis CE(2021)2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Eur Heart J 42 3599-3726
[7]
Hood WB(2014)PARADIGM-HF Investigators and Committees. Angiotensin-neprilysin inhibition versus enalapril in heart failure N Engl J Med 371 993-1004
[8]
Cohn JN(2019)EVALUATE-HF Investigators. Effect of sacubitril-valsartan vs enalapril on aortic stiffness in patients with heart failure and reduced ejection fraction: a randomized clinical trial JAMA 322 1077-1084
[9]
Cohn JN(2022)2022 AHA/ACC/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines Circulation 145 e895-e1032
[10]
Tognoni G(2020)The role of the kidney in acute and chronic heart failure Heart Fail Rev 25 107-118